Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

The Top 8 Penny Stocks to Buy for August Uncertainty

By Josh Enomoto, InvestorPlace Contributor

Penny stocks will always be risky. That said, with the huge disconnect we’re seeing in the markets, now may be a time to gamble.

A Robinhood Pop Doesn’t Make Ocugen Stock a Smart Investment

By Josh Enomoto, InvestorPlace Contributor

A disappointment throughout most of this year, OCGN stock recently shot higher. It’s very possible that enthusiastic but misguided speculators are behind this move.

How the Coronavirus and Competition Threaten Carnival

By Josh Enomoto, InvestorPlace Contributor

CCL stock was starting to look interesting. However, a cruise ship outbreak in Norway poses major challenges for the entire industry.

It’s Not Just Millenials’ Robinhood Trading That’s Driving Hertz Stock

By Josh Enomoto, InvestorPlace Contributor

Looking at Hertz stock from all angles, it’s not just dumb speculation but also consumer behavioral shifts that could be supporting the bankrupt company. However, that doesn’t make it a good idea.

Invest in Sense Diagnostics Stock for Improved Health Outcomes

By Josh Enomoto, InvestorPlace Contributor

With strokes and traumatic brain injuries being hot topics in the medical industry, many have decided to invest in Sense Diagnostics stock.

9 Boring Stocks to Buy You Should Never Let Go Of

By Josh Enomoto, InvestorPlace Contributor

These nine boring stocks to buy won’t elicit much excitement from the crowd, but they’re worthy contenders as we head toward an uncertain future.

3 Key Questions to Answer Before Buying Sorrento Therapeutics Stock

By Josh Enomoto, InvestorPlace Contributor

From relative obscurity to generated headlines, SRNE stock has jumped on big claims by Sorrento Therapeutics. You should think carefully about these three questions before placing a bet.

Tala Gives Tech Firms a Good Name, Finally!

By Josh Enomoto, InvestorPlace Contributor

Microloaning is a novel approach to connecting capital to developing countries, which is the main reason why so many people want to invest in Tala stock.

Why Nikola Stock Is Still in Tesla’s Blind Spot

By Josh Enomoto, InvestorPlace Contributor

It’s been a rough few sessions for Nikola stock, which got obliterated from its peak valuation. Still, the underlying business strategy could help fill a much-needed void.

Workhorse Group Is on the Cusp of Greatness

By Josh Enomoto, InvestorPlace Contributor

With the very real possibility of winning a $6 billion USPS contract, Workhorse Group has garnered significant interest. But you should be aware of some risks before placing your wager.

Load More